Literature DB >> 16945338

Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.

Patrycja Nowak-Sliwinska1, Andrzej Karocki, Martyna Elas, Anna Pawlak, Grazyna Stochel, Krystyna Urbanska.   

Abstract

The efficiency of photodynamic effect (PDE) for Photofrin II (PfII), Verteporfin, and Merocyanine 540 (MC540) was compared against neoplastic cells. Triplet state lifetimes and singlet molecular oxygen quantum yields were correlated with biological effect. PfII triplet lifetime was two times longer than that of Verteporfin, however, its singlet molecular oxygen quantum yield was two times lower in comparison with Verteporfin. High singlet molecular oxygen quantum yield of Verteporfin resulted in high biological efficacy. To achieve 50% mortality of cells four times lower light dose and five times lower concentration of Verteporfin were applied in comparison with PfII. The same level of cell damage was reached using 10 times higher light dose and two times higher concentration of MC540 in comparison with PfII. Our results confirm that singlet molecular oxygen based mechanism, prevalent for Verteporfin and PfII, was highly effective against melanoma cells. Verteporfin can be used at small doses with high cellular damage efficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945338     DOI: 10.1016/j.bbrc.2006.08.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway.

Authors:  Wenjing Mao; Yan Sun; Huankang Zhang; Luhong Cao; Jiajia Wang; Peijie He
Journal:  Lasers Med Sci       Date:  2016-08-01       Impact factor: 3.161

2.  Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach.

Authors:  Hyo Sung Jung; Jiyou Han; Hu Shi; Seyoung Koo; Hardev Singh; Hyo-Jin Kim; Jonathan L Sessler; Jin Yong Lee; Jong-Hoon Kim; Jong Seung Kim
Journal:  J Am Chem Soc       Date:  2017-05-10       Impact factor: 15.419

3.  Photothrombosis of corneal neovascularization by photodynamic therapy utilizing verteporfin and diode laser.

Authors:  Aziza Ahmed Hassan; Dina Foad Ghoneim; Amr Abdelraheem El-Dib; Salwa Abdelkawi Ahmed; Ahmed Medhat Abdel-Salam
Journal:  J Lasers Med Sci       Date:  2013

Review 4.  Developing strategies to predict photodynamic therapy outcome: the role of melanoma microenvironment.

Authors:  Renzo Emanuel Vera; María Julia Lamberti; Viviana Alicia Rivarola; Natalia Belén Rumie Vittar
Journal:  Tumour Biol       Date:  2015-09-29

5.  Photodynamic therapy of human lung cancer xenografts in mice.

Authors:  Chukwumere Nwogu; Paula Pera; Wiam Bshara; Kristopher Attwood; Ravindra Pandey
Journal:  J Surg Res       Date:  2015-07-17       Impact factor: 2.192

6.  Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.

Authors:  Patrycja Nowak-Sliwinska; Judy R van Beijnum; Maaike van Berkel; Hubert van den Bergh; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2010-09-15       Impact factor: 9.596

7.  Comparison of the influence of photodynamic reaction on the Me45 and MEWO cell lines in vitro.

Authors:  Anna Choromańska; Jolanta Saczko; Julita Kulbacka; Iwona Kamińska; Nina Skołucka; Michał Majkowski
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

8.  X-ray induced singlet oxygen generation by nanoparticle-photosensitizer conjugates for photodynamic therapy: determination of singlet oxygen quantum yield.

Authors:  Sandhya Clement; Wei Deng; Elizabeth Camilleri; Brian C Wilson; Ewa M Goldys
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

9.  Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.

Authors:  Diogo Silva Pellosi; Francesca Moret; Aurore Fraix; Nino Marino; Sara Maiolino; Elisa Gaio; Noboru Hioka; Elena Reddi; Salvatore Sortino; Fabiana Quaglia
Journal:  Int J Nanomedicine       Date:  2016-09-06

10.  Hyperthermia induces therapeutic effectiveness and potentiates adjuvant therapy with non-targeted and targeted drugs in an in vitro model of human malignant melanoma.

Authors:  T Mantso; S Vasileiadis; I Anestopoulos; G P Voulgaridou; E Lampri; S Botaitis; E N Kontomanolis; C Simopoulos; G Goussetis; R Franco; K Chlichlia; A Pappa; M I Panayiotidis
Journal:  Sci Rep       Date:  2018-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.